Abstract
In pediatric oncology, granulocyte colony-stimulating factor (G-CSF) is applied with the aim of shortening neutropenic periods after chemotherapy and for mobilization of peripheral blood stem cells for apheresis procedures. G-CSF is administered, subcutaneously or intravenously, on a daily basis. An insuflon device for the administration of G-CSF was used in 29 patients for 93 G-CSF periods. Retrospective evaluation shows that this administration route is feasible, safe and preferred by young children rather than by teenagers with cancer.
MeSH terms
-
Adolescent
-
Anemia, Aplastic / chemically induced
-
Anemia, Aplastic / prevention & control*
-
Antineoplastic Agents / adverse effects*
-
Child
-
Child, Preschool
-
Equipment Design
-
Equipment Safety
-
Feasibility Studies
-
Granulocyte Colony-Stimulating Factor / administration & dosage*
-
Granulocyte Colony-Stimulating Factor / adverse effects
-
Humans
-
Injections, Intravenous / instrumentation
-
Injections, Subcutaneous / instrumentation
-
Neoplasms / drug therapy*
-
Quality of Life
-
Retrospective Studies
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Granulocyte Colony-Stimulating Factor